Temozolomide Capsule
Product Images NDC 67877-542

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 67877-542). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Temo-100mg-5s (Temo 100mg 5s)

Label for Temozolomide Capsules, USP 100 mg per capsule, oral administration. The package contains 5 capsules. It includes storage instructions (25°C with permitted excursions), a caution to dispense in light-resistant containers, and notes that the drug is cytotoxic. Manufactured by Deva Holding A.S., Turkey, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. The label shows an NDC number and barcode.*

FDA Label Image

Temo-140mg-5s (Temo 140mg 5s)

Label for Temozolomide Capsules, USP 140 mg per capsule in an oral capsule dosage form. The label indicates the package contains 5 capsules and is manufactured by Deva Holding A.S., distributed by Ascend Laboratories, LLC. It includes storage instructions, dosage guidance referencing the package insert, and cautions to dispense in tight, light-resistant containers.*

FDA Label Image

Temo-180mg-5s (Temo 180mg 5s)

Label for Temozolomide Capsules USP, 180 mg per capsule, oral administration. The package contains 5 capsules. Manufactured by Deva Holding A.S., distributed by Ascend Laboratories, LLC. The label includes dosage instructions, storage temperature guidance, and barcodes.*

FDA Label Image

Temo-20mg-5s (Temo 20mg 5s)

Label for Temozolomide Capsules USP 20 mg oral capsules by Ascend Laboratories, LLC. The package contains 5 capsules. The label includes storage instructions, dosage guidance, cytotoxic warning, manufacturer and distributor information, and the NDC code 67877-538-07.*

FDA Label Image

Temo-250mg-5s (Temo 250mg 5s)

Label for Temozolomide Capsules USP, 250 mg per capsule, oral administration by Ascend Laboratories, LLC. The package contains 5 capsules. The label includes storage instructions at 25°C with permitted excursions and cautions for handling cytotoxic medication. Manufacturer is Deva Holding A.S., Istanbul, Turkey.*

FDA Label Image

Temo-5mg-5s (Temo 5mg 5s)

Label for Temozolomide Capsules, USP 5 mg, oral capsules by Ascend Laboratories, LLC. The package contains 5 capsules. The label includes storage instructions, manufacturer Deva Holding A.S. in Turkey, and distributor Ascend Laboratories, LLC details. It is marked cytotoxic with directions to read accompanying instructions carefully.*

FDA Label Image

Kaplan-meier Curves (Temo Fig2)

A Kaplan-Meier survival curve titled 'ITT Population: Overall Survival' showing probability of survival over time from randomization in months. The graph compares two groups: 'RT + TMZ' and 'RT Only', with 'RT + TMZ' having higher survival probability over time. The hazard ratio (HR) with 95% confidence interval and log-rank p-value are noted, indicating statistical significance.*

FDA Label Image

Temo-fig4-logo (Temo Fig4 Logo)

FDA Label Image

Temo-fig5-logo (Temo Fig5 Logo)

FDA Label Image

Chemical-structure (Temo Structure)

Chemical structure diagram of Temozolomide, showing its molecular framework with labeled atoms including nitrogen, oxygen, and methyl group attached to the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.